Predicting Survival in Bladder Cancer After Immunotherapy – LWW Journals
|
Predicting Survival in Bladder Cancer After Immunotherapy
LWW Journals SAN FRANCISCO—Researchers have developed a model to predict overall survival for people with advanced urothelial cancers treated with the immune checkpoint inhibitor atezolizumab. The model, which is based on six clinical factors, may help inform … |
